Online or sell prescription drugs the share of pharmaceutical dealers will multiply

Pharmaceutical electrical Business industry, or will usher in another policy positive promotion.

May 28, the National Food and Drug Administration official website hangs out the "Internet Food and drug management measures (draft)" (hereinafter referred to as the draft), formally to the community to seek revised views.

"Daily economic News" reporter detailed reading of the draft found that, and the past, compared with the relevant industry policy of pharmaceutical manufacturers, the comments on the draft of the reform ideas, broke the past has been entrenched in the two areas of policy barriers, one point is that if the requirements of the regular internet pharmacies can sell prescription drugs, Another point is that the operation of the third party trading platform will be more relaxed.

"This is a great positive, I hope the policy will fall, I very much support the draft, the industry reflects the voice of the." "The day after the release of the opinion, to Ling Health City deputy general manager, Ling Pharmaceutical Electric Business Division general Manager Shaoqing, may represent the voice of the industry."

Selling prescription drugs online "precedent"

The above comments, which are welcomed by the pharmaceutical dealers, have broken the taboo that the network cannot sell prescription drugs. If the draft of this opinion can be successfully landed, "Internet drug operators shall, in accordance with the requirements of the administration of drug classification, sell prescription drugs by prescription, and the standard, format and validity period of the prescriptions shall conform to the relevant provisions of the administration of prescriptions".

Authoritative data show that the current drug regulatory authorities approved the legal online drug retail enterprises have 129, online drug sales must have the "Internet Drug trading service certificate." All to consumers retail drugs, the first should be drug retail chain enterprises, followed by its own web site equipment and management capabilities, in line with the relevant examination and approval provisions.

Guoqing, Director of Drug Administration at a meeting, told reporters at a conference that the current online drug sales business is not profitable, and depends on other goods to make up. Mainly by the prescription sources and health insurance reimbursement restrictions, retail channels to sell drugs accounted for only 20% of China's drug sales.

In Guoqing's view, the opening of online marketing channels, and can not increase the overall volume of drug sales. Guoqing said that the drug as a special commodity, storage and transport have special requirements, the current General Express Company's management level and conditions also can not reach the requirements of drug delivery, drugs in the delivery of the risk is difficult to control. In view of the drug quality assurance, the Drug Administration department is currently not allowed to entrust social organizations to direct distribution of drugs to consumers. However, with the development of the pharmaceutical and electrical industry, the FDA's regulatory policy has changed, and for the first time, it has revealed that it will relax the direction of Internet pharmacies selling prescription drugs online.

Increase in the share of pharmaceutical and electronic business

The release of the draft, from the policy-oriented perspective, will be the pharmaceutical and electrical industry has a major positive. In Shaoqing's view, the domestic pharmaceutical and electrical industry has long been plagued by policy tightening, not large-scale development. The data show that, from the sales point of view, the foreign pharmaceutical electric dealers accounted for the overall sales of about 30%, while China's pharmaceutical manufacturers accounted for less than 0.1%.

If this draft can be landed, it can effectively reduce the price of medicine, breaking the relevant large hospitals, drugs and local governments in the drug bidding process to enforce monopoly and raise the price of drugs.

"Because the Internet is a complete competitive market, there is no gray rebate and rebate, coupled with a lot of business subjects, will naturally produce competition, thus optimizing the market, and can combat the online sale of counterfeit drugs." Shaoqing told reporters that the market economy will drive these counterfeit businesses out of business after the online sale of prescription drugs is fully formalized.

In Zhuo Chuang Information Medicine industry analyst Zhao, the domestic current prescription drug accounted for more than 80% market share, in the past, pharmaceutical dealers can only contact 20% of the market share. If the draft fell to the ground, the pharmaceutical industry market share on a sudden magnified 5 times times, this is a very big positive.

With regard to the difficulty of regulation, Zhao said that it could draw on the experience that developed countries have been running for years on the internet to sell prescription drugs. "The difficulty of regulation is actually less difficult than that of selling drugs under the line, and the risk is more manageable." "According to the mature monitoring experience in Europe and America, Zhao said in the future when monitoring, you can backtrack on the network, tracking the drug sellers and drug buyers of personal information, the number of drug purchase and drug purchase time, in the network technology and electronic information development mature now, in China to achieve a network of drug sales monitoring supervised is not difficult. If the future regulatory level can further open up health care, that is, the Internet to buy medicine through Medicare reimbursement, will "stimulate the rapid development of the industry."

Planning a third party trading platform

In addition to the prescription drug sales taboo is expected to break, the draft also for the first time on Third-party trading platform to make policy planning, further promote the industry development.

It is reported that the third party trading platform refers to the Internet food and drug business activities for the two or more parties to provide web space, virtual business sites, trading rules, transaction matchmaking, electronic orders and other services for the transaction of both sides or parties to carry out the transaction activities of the information network system.

It is clear from the draft that the third party trading platform operators should examine the qualification of the food and drug operators who apply for entry into the platform, establish the registration files and verify the renewal of the business license, business license or record information in time.

Yang Quanju, chairman of China Pharmaceutical Materials Association, Shanxi Renhe Pharmacy Chain Co., Ltd., said that in the field of medicine, the future reform is worth exploring a path is to open up a third party medicine logistics Platform as soon as possible in the country. The trend of the development of the whole industry in the future is merger and reorganization and increasing market concentration.

The generation of third party logistics trading platform, will also be the development of a single pharmacy good, because in the past according to the state Food and drug supervision of the existing policy provisions, such as the new version of GSP, on the single pharmacy put forward a more stringent requirements, certification costs are very high, and even difficult to pass the certification, in the drug delivery and other aspects of

In Yang Quanju view, if the future can be in the face of the demand for more stringent requirements, as soon as possible to join the chain of pharmacies, by hanging a chain of brands to complete distribution, or directly to the chain, or a joint venture, integrated to complete distribution.

If the draft is on the ground, the future "third-party medicine logistics platform will be upstream supply enterprises of drug procurement and other links in the industrial chain, play an effective role." Most crucially, the scale effect will be generated, market resources are highly concentrated, to a certain extent, to reduce the price of medicine, Yang Quanju reporters.